electrostatic interaction and thus intracellular release of free DNA for transcription is the main barrier to efficient DNA transfection [3, 4] .
In a recent online publication of Advanced Materials, Professor Youqing Shen from Zhejiang University reports a very motivating design of reactive oxygen species (ROS)-labile charge-reversal polymer-based fusogenic lipidic polyplexes (FLPPs), which are promising to successfully overcome these problems ( Fig. 1 ) [5] . One key design is the charge-reversal moiety, a quaternary ammonium Gene therapy is known highly effective for treatment of many diseases; however, its wide use has been severely bottlenecked by lack of safe and effective delivery vectors [1] . Cationic polymers are safe nonviral gene vectors with great potential for large-scale applications [2] , and widely used to condense the large macromolecules into cationic polymer/DNA complexes (polyplexes) nanoparticles, protecting them from degradation and facilitating their cellular internalization. However, once inside the cells, unzipping the cationic polymer/DNA complexes is against the strong 
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with a benzylboronic acid. Upon oxidation of the boronic acid group by intracellular ROS (e.g., H 2 O 2 ), which are known to be elevated in cancerous cells [6] and capable of oxidizing benzylboronic acid/esters [7] , the quaternary ammonium releases p-hydroxylmethylenephenol (HMP) [8] and becomes a tertiary amine, which self-catalyzes further hydrolysis of the polyacrylic ester into poly(acrylic acid). The second key design is the fusogenic lipid coating. Different from the most lipopolyplexes which are internalized by endocytosis and thus may be trapped in lysosomes causing DNA degradation, a pegylated lipid layer was finely tuned and coated to the charge-reversal polyplexes so that the lipidic polyplexes nanoparticles (FLPP) were able to fuse with the cell membrane, ejecting the polyplexes into the cytosol. Such viropexis-mimicking process avoids the endosomal trapping and DNA degradation. Most importantly, the CRGKD-targeting FLPPs were stable and long circulating in the bloodstream and capable of actively targeting tumors, and successfully delivered reporter genes and suicidal TRAIL gene to tumor xenografts, producing significantly better tumor growth inhibition than doxorubicin. This is the first such design with a novel ROS-responsive charge-reversal polymer that can simultaneously overcome the key problems of cationic polymer-based gene delivery. The concept of using fusogenic lipidic polyplex may be applied to other cationic polymer gene delivery systems.
